Diagnostics Solutions Strategic Priorities

New innovations driving market access Mass Spectrometry First fully integrated mass spectrometry Emerging Market Analyzer Routing testing in remote areas col Integration of mass spec into the Core Lab Sample in result out - Increase patient access to mass spec technology Promising new high medical value biomarkers Designed for the specific needs of emerging markets • Compact, easy-to-operate benchtop analyzer Combines immunochemistry and clinical chemistry into one box CHF 2.1 billion accessible market CHF 2 billion accessible market Roche 44

View entire presentation